Effect of high-dose plerixafor on CD34(+) cell mobilization in healthy stem cell donors: results of a randomized crossover trial

Hematopoietic stem cells can be mobilized from healthy donors using single-agent plerixafor without granulocyte colony-stimulating factor and, following allogeneic transplantation, can result in sustained donor-derived hematopoiesis. However, when a single dose of plerixafor is administered at a con...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantin, Jeremy, Purev, Enkhtsetseg, Tian, Xin, Cook, Lisa, Donohue-Jerussi, Theresa, Cho, Elena, Reger, Robert, Hsieh, Matthew, Khuu, Hanh, Calandra, Gary, Geller, Nancy L., Childs, Richard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394957/
https://www.ncbi.nlm.nih.gov/pubmed/27846612
http://dx.doi.org/10.3324/haematol.2016.147132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394957/
https://www.ncbi.nlm.nih.gov/pubmed/27846612
http://dx.doi.org/10.3324/haematol.2016.147132

Ejemplares similares